Outcomes of simultaneous heart–kidney and lung–kidney transplantations: the <scp>A</scp>ustralian and <scp>N</scp>ew <scp>Z</scp>ealand experience

Abstract

The Australian and New Zealand experience of SHK and SLK includes 38 patients with a high 1-year mortality, but excellent 5- and 10-year survivals. Based on this, it seems reasonable to continue to offer combined organ transplantation to select patients with dual organ failure.